Health outcomes attributable to carbapenemase-producing Enterobacteriaceae infections: A systematic review and meta-analysis

被引:22
|
作者
Budhram, Dalton R. [1 ]
Mac, Stephen [2 ,3 ]
Bielecki, Joanna M. [3 ]
Patel, Samir N. [4 ,5 ]
Sander, Beate [2 ,3 ,4 ,6 ]
机构
[1] Queens Univ, Dept Med, Kingston, ON, Canada
[2] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[3] Univ Hlth Network, Toronto Hlth Econ & Technol Assessment THETA Coll, Toronto, ON, Canada
[4] Publ Hlth Ontario, Publ Hlth Ontario Lab, 661 Univ Ave, Toronto, ON, Canada
[5] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[6] Inst Clin Evaluat Sci, Toronto, ON, Canada
关键词
CARE-UNIT PATIENTS; KLEBSIELLA-PNEUMONIAE; RISK-FACTORS; RESISTANT ENTEROBACTERIACEAE; BETA-LACTAMASE; MORTALITY; IMPACT; COLONIZATION;
D O I
10.1017/ice.2019.282
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Carbapenemase-producing Enterobacteriaceae (CPE) pose a significant global health threat. Objective: To conduct a systematic review of health outcomes and long-term sequelae attributable to CPE infection. Methods: We followed PRISMA reporting guidelines and published our review protocol on PROSPERO (CRD42018097357). We searched Medline, Embase, CINAHL and the Cochrane Library. We included primary studies with a carbapenem-susceptible control group in high-income countries, published in English. Quality appraisal was completed using Joanna Briggs Institute checklists. We qualitatively summarized frequently reported outcomes and conducted a meta-analysis. Results: Our systematic review identified 8,671 studies; 17 met the eligibility criteria for inclusion. All studies reported health outcomes; none reported health-related quality-of-life. Most studies were from Europe (65%), were conducted in teaching or university-affiliated hospitals (76%), and used case-control designs (53%). Mortality was the most commonly reported consequence of CPE-infections; in-hospital mortality was most often reported (62%). Our meta-analysis (n = 5 studies) estimated an absolute risk difference (ARD) for in-hospital bloodstream infection mortality of 0.25 (95% confidence interval [CI], 0.17-0.32). Duration of antibiotic therapy (range, 4-29.7 vs 1-23.6 days) and length of hospital stay (range, 21-87 vs 15-43 days) were relatively higher for CPE-infected patients than for patients infected with carbapenem-susceptible pathogens. Most studies (82%) met >80% of their respective quality appraisal criteria. Conclusions: The risk of in-hospital mortality due to CPE bloodstream infection is considerably greater than carbapenem-susceptible bloodstream infection (ARD, 0.25; 95% CI, 0.17-0.32). Health outcome studies associated with CPE infection are focused on short-term (eg, in-hospital) outcomes; long-term sequelae and quality-of-life are not well studied.
引用
收藏
页码:37 / 43
页数:7
相关论文
共 50 条
  • [31] Community-Onset Bloodstream and Other Infections, Caused by Carbapenemase-Producing Enterobacteriaceae: Epidemiological, Microbiological, and Clinical Features
    Ramon Pano-Pardo, Jose
    Lopez Quintana, Beatriz
    Lazaro Perona, Fernando
    Ruiz Carrascoso, Guillermo
    Pilar Romero-Gomez, Maria
    Loeches Yague, Belen
    Diaz-Pollan, Beatriz
    Martinez-Virto, Ana
    Mingorance, Jesus
    Garcia Rodriguez, Julio
    Ramon Arribas, Jose
    Gomez-Gil, Rosa
    OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (03):
  • [32] Risk Factors for Intra-Abdominal Infections Caused by Carbapenemase-Producing Enterobacteriaceae in a Surgical Setting
    Mora-Guzman, Ismael
    Rubio-Perez, Ines
    Domingo-Garcia, Diego
    Martin-Perez, Elena
    SURGICAL INFECTIONS, 2021, 22 (08) : 864 - 870
  • [33] Adverse clinical outcomes associated with infections by Enterobacterales producing ESBL (ESBL-E): a systematic review and meta-analysis
    Ling, Weiping
    Furuya-Kanamori, Luis
    Ezure, Yukiko
    Harris, Patrick N. A.
    Paterson, David L.
    JAC-ANTIMICROBIAL RESISTANCE, 2021, 3 (02):
  • [34] .0Description of carbapenemase-producing Enterobacteriaceae isolates in a Spanish tertiary hospital. Epidemiological analysis and clinical impact
    Lopez-Gonzalez, Laura
    Manuel Vinuela-Prieto, Jose
    Rodriguez-Avial, Iciar
    Manzano, Rocio
    Javier Candel, Francisco
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2019, 32 (03) : 254 - 262
  • [35] Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis
    Beaudart, Charlotte
    Zaaria, Myriam
    Pasleau, Francoise
    Reginster, Jean-Yves
    Bruyere, Olivier
    PLOS ONE, 2017, 12 (01):
  • [36] Outbreak of Klebsiella pneumoniae carbapenemase-producing K pneumoniae: A systematic review
    Campos, Anaelis C.
    Albiero, James
    Ecker, Alessandra B.
    Kuroda, Cristina M.
    Meirelles, Livia E. F.
    Polato, Angelita
    Tognim, Maria C. B.
    Wingeter, Marcia A.
    Teixeira, Jorge J. V.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2016, 44 (11) : 1374 - 1380
  • [37] Who should be screened for carbapenemase-producing Enterobacterales and when? A systematic review
    Bar Ilan, M.
    Kjerulf, A.
    JOURNAL OF HOSPITAL INFECTION, 2023, 142 : 74 - 87
  • [38] Polypharmacy and health outcomes in atrial fibrillation: a systematic review and meta-analysis
    Gallagher, Celine
    Nyfort-Hansen, Karin
    Rowett, Debra
    Wong, Christopher X.
    Middeldorp, Melissa E.
    Mahajan, Rajiv
    Lau, Dennis H.
    Sanders, Prashanthan
    Hendriks, Jeroen M.
    OPEN HEART, 2020, 7 (01):
  • [39] Intra-Abdominal Infections by Carbapenemase-Producing Enterobacteriaceae in a Surgical Unit: Counting Mortality, Stay, and Costs
    Mora-Guzman, Ismael
    Rubio-Perez, Ines
    Domingo-Garcia, Diego
    Martin-Perez, Elena
    SURGICAL INFECTIONS, 2021, 22 (03) : 266 - 273
  • [40] Infections by OXA-48 carbapenemase-producing Enterobacteriaceae in surgical patients: antibiotic consumption and susceptibility patterns
    Mora-Guzman, Ismael
    Rubio-Perez, Ines
    Domingo-Garcia, Diego
    Martin-Perez, Elena
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2020, 33 (06) : 448 - 452